Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-800
Closed -$262K 34
2025
Q4
$262K Buy
+800
New +$254K 0.59% 64
2024
Q1
Sell
-163
Closed -$46.9K 116
2023
Q4
$46.9K Buy
+163
New +$44.4K 0.1% 179
2023
Q3
Sell
-72
Closed -$16K 601
2023
Q2
$16K Buy
+72
New +$16.7K 0.01% 366

Other funds holding AMGN

West Tower Group's AMGN Position: Q1 2026 in Review

West Tower Group sold out of Amgen (AMGN) in Q1 2026, closing a stake of 800 shares — an estimated $262K sold.

West Tower Group first reported a position in AMGN in Q2 2023 and held it in 3 quarters. The position peaked at $262K in Q4 2025. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • West Tower Group reported no remaining Amgen position as of Q1 2026 after selling out during the quarter.
  • West Tower Group sold 800 Amgen shares in Q1 2026, an estimated $262K.
  • West Tower Group first reported a position in Amgen in Q2 2023 and held it in 3 quarters.
  • West Tower Group's Amgen position peaked at $262K in Q4 2025.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on West Tower Group's 13F filing for Q1 2026, filed 29 Apr 2026.